Identifying the Key Determinators for Designing a Holistic Model for Improved Operating Conditions of the Indian Pharmaceutical Companies

Abstract

The study discusses the evaluation and growth of the Indian pharmaceutical industry and also presenting the historical background by explaining several drivers behind the growth and policies provided by the government. The article also provides the industry analysis and several strategies that are adopted by the Indian pharmaceutical companies to ensure their growth through generics, biosimilar, and other formulations. The study also discuss the future growth and challenges of Indian pharmaceutical company and also analyze the need to address by industry and government to achieve     the       Pharma            vision   2020 effectively.